Form 4: Alumis Director Sapna Srivastava Granted 49,800 Stock Options

Alumis Inc. Director Sapna Srivastava was granted 49,800 stock options with an exercise price of $4.10, vesting over time or upon a change in control.

Summary

• Sapna Srivastava, a Director of Alumis Inc. (ALMS), was granted 49,800 stock options.
• The options have an exercise price of $4.10 per share.
• The grant date for these options was July 30, 2025.
• The options are set to expire on July 29, 2035.
• Vesting occurs on the first anniversary of the grant date, provided continuous service is maintained.
• Options will be fully vested on the date of Alumis Inc.'s 2026 annual stockholder meeting, subject to continuous service.
• Full vesting will also occur upon a Change in Control, contingent on continuous service.
• The options are for the right to buy 49,800 shares of Common Stock.
• The reporting person beneficially owns 49,800 derivative securities directly following this transaction.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a routine corporate governance practice aimed at aligning the director's interests with those of shareholders, indicating a commitment to long-term value creation. It is a neutral to slightly positive event as it reinforces governance alignment.

Positives

• The grant of stock options to a director aligns their interests with those of shareholders, incentivizing long-term value creation.
• The equity incentive plan provides a mechanism for attracting and retaining key personnel.

Negatives

• No immediate negative implications are apparent from this routine insider transaction filing.

Risks

• Potential forfeiture of the granted stock options if the reporting person's continuous service with Alumis Inc. is not maintained through the specified vesting dates.
• The value of the options is dependent on the future market price of Alumis Inc. common stock exceeding the exercise price of $4.10.

Future Outlook

The vesting schedule for the granted stock options indicates a long-term incentive for the director, aligning their future financial interests with the company's performance and shareholder value creation.

Management Comments

• No direct management quotes are provided in this Form 4 filing, which is a standard disclosure for insider transactions.

Industry Context

The granting of stock options to directors is a common and widely accepted practice within the public company landscape. It serves as a key component of executive and director compensation, designed to align the interests of company leadership with those of shareholders by tying compensation to the company's stock performance.

Comparison to Industry Standards

• Granting stock options to directors is a standard compensation practice across various industries, including biotechnology and pharmaceuticals, to incentivize long-term commitment and performance.
• The vesting schedule, which includes time-based vesting and accelerated vesting upon a change in control, is typical for equity incentive plans in publicly traded companies.

Corporate Governance

Related Party Transactions

• The grant of 49,800 stock options to Sapna Srivastava, a director of Alumis Inc., constitutes a related party transaction as it involves compensation provided to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial incentives with the company's stock performance, potentially benefiting shareholders through improved governance and long-term strategic focus.
• Employees: While this specific grant is to a director, it is part of a broader equity incentive plan that may also benefit other key employees, fostering a culture of shared ownership and performance.

Next Steps

• The granted options will begin to vest on the first anniversary of the grant date (July 30, 2026).
• The options will continue to vest until fully vested on the date of the Issuer's 2026 annual stockholder meeting, or earlier upon a Change in Control, subject to continuous service.
• The reporting person may choose to exercise the options at any time after vesting and before the expiration date of July 29, 2035.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a director, which is a common practice for incentivizing long-term commitment and aligning interests with shareholders. It does not contain information that would significantly alter the investment thesis for Alumis Inc. at this time, thus a 'hold' recommendation is appropriate.

Keywords

Alumis Inc., ALMS, Stock Option, Director, Equity Grant, Insider Transaction, SEC Form 4, Sapna Srivastava, Vesting